Mesenchymal stem cell-like properties in fibroblasts

Cellular Physiology and Biochemistry

Volumn 34, Issue 3, 2014, Pages 703-714

  Chang, Yuqiao ^a,b   Li, He ^a   Guo, Zhikun ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Directed differentiation; Epithelial mesenchymal transition; Fibroblasts; Mesenchymal stem cells; Mesenchymal to epithelial transition

Indexed keywords

MOLECULAR MARKER;

CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; FIBROBLAST; HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; CYTOLOGY; EPITHELIAL MESENCHYMAL TRANSITION; MESENCHYMAL STROMA CELL;

EPITHELIAL-MESENCHYMAL TRANSITION; FIBROBLASTS; HUMANS; MESENCHYMAL STROMAL CELLS;

EID: 84906637896     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000363035     Document Type: Review

References (83)

1. Sisson TH, Maher TM, Ajayi IO, King JE, Higgins PD, Booth AJ, Sagana RL, Huang SK, White ES, Moore BB, Horowitz JC: Increased survivin expression contributes to apoptosis-resistance in IPF fibroblasts. Adv Biosci Biotechnol 2012;3:657-664.
2. Abdalla M, Goc A, Segar L, Somanath PR: Akt1 mediates alpha-smooth muscle actin expression and myofibroblast differentiation via myocardin and serum response factor. J Biol Chem 2013;288:33483-33493.
3. Rodemann HP, Muller GA, Knecht A, Norman JT, Fine LG: Fibroblasts of rabbit kidney in culture. I. Characterization and identification of cell-specific markers. Am J Physiol 1991;261:F283-F291.
4. Cramer LP, Siebert M, Mitchison TJ: Identification of novel graded polarity actin filament bundles in locomoting heart fibroblasts: implications for the generation of motile force. J Cell Biol 1997;136:1287-1305.
5. Phipps RP, Borrello MA, Blieden TM: Fibroblast heterogeneity in the periodontium and other tissues. J Periodontal Res 1997;32:159-165.
6. Fries KM, Blieden T, Looney RJ, Sempowski GD, Silvera MR, Willis RA, Phipps RP: Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis. Clin Immunol Immunopathol 1994;72:283-292.
7. Lekic PC, Pender N, McCulloch CA: Is fibroblast heterogeneity relevant to the health, diseases, and treatments of periodontal tissues? Crit Rev Oral Biol Med 1997;8:253-268.
8. Snider P, Standley KN, Wang J, Azhar M, Doetschman T, Conway SJ: Origin of cardiac fibroblasts and the role of periostin. Circ Res 2009;105:934-947.
9. Coles B, Fielding CA, Rose-John S, Scheller J, Jones SA, O'Donnell VB: Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo. Am J Pathol 2007;171:315-325.
10. Zhao XF, Wang DL, Wei ZR, Xue QY, Yu LM: The research of fibroblasts from human hypertrophic scar showing a mesenchymal stem cell phenotype and multilineage differentiation potentialities. Zhonghua Zheng Xing Wai Ke Za Zhi 2013;29:273-279.
11. Haniffa MA, Collin MP, Buckley CD, Dazzi F: Mesenchymal stem cells: the fibroblasts' new clothes? Haematologica 2009;94:258-263.
12. Lin GL, Hankenson K D: Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation. J Cell Biochem 2011;112:3491-3501.
13. Junker JP, Sommar P, Skog M, Johnson H, Kratz G: Adipogenic, chondrogenic and osteogenic differentiation of clonally derived human dermal fibroblasts. Cells Tissues Organs 2010;191:105-118.
14. Kalluri R, Zeisberg M: Fibroblasts in cancer. Nat Rev Cancer 2006;6:392-401.
15. Chang HY, Chi JT, Dudoit S, Bondre C, van de Rijn M, Botstein D, Brown PO: Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci U S A 2002;99:12877-12882.
16. Camelliti P, Borg TK, Kohl P: Structural and functional characterisation of cardiac fibroblasts. Cardiovasc Res 2005;65:40-51.
17. Corda S, Samuel JL, Rappaport L: Extracellular matrix and growth factors during heart growth. Heart Fail Rev 2000;5:119-130.
18. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN: Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001;166:7556-7562.
19. Goldsmith EC, Hoffman A, Morales MO, Potts JD, Price RL, McFadden A, Rice M, Borg TK: Organization of fibroblasts in the heart. Dev Dyn 2004;230:787-794.
20. Kohl P, Camelliti P, Burton FL, Smith GL: Electrical coupling of fibroblasts and myocytes: relevance for cardiac propagation. J Electrocardiol 2005;38:45-50.
21. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, Neilson EG, Sayegh MH, Izumo S, Kalluri R: Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007;13:952-961.
22. Banerjee I, Yekkala K, Borg TK, Baudino TA: Dynamic interactions between myocytes, fibroblasts, and extracellular matrix. Ann N Y Acad Sci 2006;1080:76-84.
23. Ieda M, Tsuchihashi T, Ivey KN, Ross RS, Hong TT, Shaw RM, Srivastava D: Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling. Dev Cell 2009;16:233-244.
24. Soonpaa MH, Kim KK, Pajak L, Franklin M, Field LJ: Cardiomyocyte DNA synthesis and binucleation during murine development. Am J Physiol 1996;271:H2183-H2189.
25. Zak R: Development and proliferative capacity of cardiac muscle cells. Circ Res 1974;35:suppl II:17-26.
26. Nag AC: Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution. Cytobios 1980;28:41-61.
27. Camelliti P, Green CR, LeGrice I, Kohl P: Fibroblast network in rabbit sinoatrial node: structural and functional identification of homogeneous and heterogeneous cell coupling. Circ Res 2004;94:828-835.
28. Kohl P: Cardiac cellular heterogeneity and remodelling. Cardiovasc Res 2004;64:195-197.
29. Rossini M, Cheunsuchon B, Donnert E, Ma LJ, Thomas JW, Neilson EG, Fogo AB: Immunolocalization of fibroblast growth factor-1 (FGF-1), its receptor (FGFR-1), and fibroblast-specific protein-1 (FSP-1) in inflammatory renal disease. Kidney Int 2005;68:2621-2628.
30. Cossu G, Bianco P: Mesoangioblasts-vascular progenitors for extravascular mesodermal tissues. Curr Opin Genet Dev 2003;13:537-542.
31. Sartore S, Chiavegato A, Faggin E, Franch R, Puato M, Ausoni S, Pauletto P: Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant. Circ Res 2001;89:1111-1121.
32. Sundberg C, Ivarsson M, Gerdin B, Rubin K: Pericytes as collagen-producing cells in excessive dermal scarring. Lab Invest 1996;74:452-466.
33. Perez-Pomares JM, Carmona R, Gonzalez-Iriarte M, Atencia G, Wessels A, Munoz-Chapuli R: Origin of coronary endothelial cells from epicardial mesothelium in avian embryos. Int J Dev Biol 2002;46:1005-1013.
34. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN: Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001;166: 7556-7562
35. Shrivastava A, Radziejewski C, Campbell E, Kovac L, McGlynn M, Ryan TE, Davis S, Goldfarb MP, Glass DJ, Lemke G, Yancopoulos: An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Mol Cell 1997;1:25-34.
36. Vogel W, Gish GD, Alves F, Pawson T: The discoidin domain receptor tyrosine kinases are activated by collagen. Mol Cell 1997;1:13-23.
37. Schlessinger J: Direct binding and activation of receptor tyrosine kinases by collagen. Cell 1997;91:869-872.
38. Chin GS, Lee S, Hsu M, Liu W, Kim WJ, Levinson H, Longaker MT: Discoidin domain receptors and their ligand, collagen, are temporally regulated in fetal rat fibroblasts in vitro. Plast Reconstr Surg 2001;107:769-776.
39. Wang X, Khaidakov M, Ding Z, Dai Y, Mercanti F, Mehta JL: LOX-1 in the maintenance of cytoskeleton and proliferation in senescent cardiac fibroblasts. J Mol Cell Cardiol 2013; 60:184-190.
40. Zucchini A, Del Zotto G, Brando B, Canonico B: CD90. J Biol Regul Homeost Agents 2001;15:82-85.
41. Baglole CJ, Reddy SY, Pollock SJ, Feldon SE, Sime PJ, Smith TJ, Phipps RP: Isolation and phenotypic characterization of lung fibroblasts. Methods Mol Med 2005;117: 115-127.
42. Hagood JS, Miller PJ, Lasky JA, Tousson A, Guo B, Fuller GM, Mslntosh JC: Differential expression of plateletderived growth factor-alpha receptor by Thy-1(-) and Thy-1(+) lung fibroblasts. Am J Physiol 1999;277: L218-L224.
43. Koumas L, King AE, Critchley HO, Kelly RW, Phipps RP: Fibroblast heterogeneity: existence of functionally distinct Thy 1+ and Thy 1- human female reproductive tract fibroblasts. A J Pathol 2001;159:925-935.
44. Koumas L, Smith TJ, Phipps RP: Fibroblast subsets in the human orbit: Thy-1+ and Thy-1-subpopulations exhibit distinct phenotypes. Eur J Immunol 2002;32:477-485.
45. Hudon-David F, Bouzeghrane F, Couture P, Thibault G: Thy-1 expression by cardiac fibroblasts: lack of association with myofibroblast contractile markers. J Mol Cell Cardiol 2007;42:991-1000.
46. Kaufman J, Graf BA, Leung EC, Pollock SJ, Koumas L, Reddy SY, Blieden TM, Smith TJ, Phipps RP: Fibroblasts as sentinel cells: role of the CDcd40-CDcd40 ligand system in fibroblast activation and lung inflammation and fibrosis. Chest 2001;120:53S-55S.
47. Derdak S, Penney DP, Keng P, Felch ME, Brown D, Phipps RP: Differential collagen and fibronectin production by Thy 1+ and Thy 1-lung fibroblast subpopulations. Am J Physiol 1992;263:L283-L290.
48. Sanders YY, Kumbla P, Hagood JS: Enhanced myofibroblastic differentiation and survival in Thy-1(-) lung fibroblasts. Am J Respir Cell Mol Biol 2007;36:226-235.
49. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, Neilson EG: Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 1995;130:393-405.
50. Mazzucchelli L: Protein S100A4: too long overlooked by pathologists? Am J Pathol 2002;160:7-13.
51. Kraman M, Bambrough PJ, Arnold JN, Roberts EW, Magiera L, Jones JO, Gopinathan A, Tuveson DA, Fearon DT: Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. Science 2010;330:827-830.
52. Bouzeghrane F, Mercure C, Reudelhuber TL, Thibault, G: Alpha8beta1 integrin is upregulated in myofibroblasts of fibrotic and scarring myocardium. J Mol Cell Cardiol 2004;36:343-353.
53. Thibault G, Lacombe MJ, Schnapp LM, Lacasse A, Bouzeghrane F, Lapalme G: Upregulation of alpha(8) beta(1)-integrin in cardiac fibroblast by angiotensin II and transforming growth factor-beta1. Am J Physiol Cell Physiol 2001;281:C1457-C1467.
54. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A; International Society for Cellular Therapy: Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005;7:393-395.
55. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317.
56. Saeed H, Taipaleenmaki H, Aldahmash AM, Abdallah BM, Kassem M: Mouse embryonic fibroblasts (MEF) exhibit a similar but not identical phenotype to bone marrow stromal stem cells (BMSC). Stem Cell Rev 2012;8:318-328.
57. Szabo E, Rampalli S, Risueňo RM, Schnerch A, Mitchell R, Fiebig-Comyn A, Levadoux-Martin M, Bhatia M: Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 2010;468:521-526.
58. Cauffman G, Van de Velde H, Liebaers I, Van Steirteghem A: Oct-4 mRNA and protein expression during human preimplantation development. Mol Hum Reprod 2005;11:173-181.
59. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676.
60. Panopoulos AD, Ruiz S, Izpisua Belmonte JC: iPSCs: induced back to controversy. Cell Stem Cell 2011;8:347-348.
61. Ben-David U, Benvenisty N: The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer 2011;11:268-277.
62. Asuelime GE, Shi Y: A case of cellular alchemy: lineage reprogramming and its potential in regenerative medicine. J Mol Cell Biol 2012;4:190-196.
63. Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG, Srivastava D: Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010;142:375-386.
64. Qian L, Huang Y, Spencer CI, Foley A, Vedanthan V, Liu L, Conway SJ, Fu JD, Srivastava D: In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012;485:593-598.
65. Song K, Nam YJ, Luo X, Qi X, Tan W, Huang GN, Acharya A, Smith CL, Tallquist MD, Neilson EG, Hill JA, Bassel-Duby R, Olson EN: Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 2012;485:599-604.
66. Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Sudhof TC, Wernig M: Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010;463:1035-1041.
67. Pfisterer U, Kirkeby A, Torper O, Wood J, Nelander J, Dufour A, Björklund A, Lindvall O, Jakobsson J, Parmar M: Direct conversion of human fibroblasts to dopaminergic neurons. Proc Natl Acad Sci U S A 2011;108:10343-10348.
68. Zhang K, Liu GH, Yi F, Montserrat N, Hishida T, Rodriguez Esteban C, Izpisua Belmonte JC: Direct conversion of human fibroblasts into retinal pigment epithelium-like cells by defined factors. Protein Cell 2014;5:48-58.
69. Haniffa MA, Wang XN, Holtick U, Rae M, Isaacs JD, Dickinson AM, Hilken CM, Collin MP: Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J Immunol 2007;179:1595-1604.
70. Lysy PA, Smets F, Sibille C, Najimi M, Sokal EM: Human skin fibroblasts: From mesodermal to hepatocytelike differentiation. Hepatology 2007;46:1574-1585.
71. Cappellesso-Fleury S, Puissant-Lubrano B, Apoil PA, Titeux M, Winterton P, Casteilla L, Bourin P, Blancher A: Human fibroblasts share immunosuppressive properties with bone marrow mesenchymal stem cells. J Clin Immunol 2010;30:607-619.
72. Lorenz K, Sicker M, Schmelzer E, Rupf T, Salvetter J, Schulz-Siegmund M, Bader A: Multilineage differentiation potential of human dermal skin-derived fibroblasts. Exp Dermatol 2008;17:925-932.
73. Crigler L, Robey RC, Asawachaicharn A, Gaupp D, Phinney DG: Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol 2006;198:54-64.
74. Toma JG, Akhavan M, Fernandes KJ, Barnabé-Heider F, Sadikot A, Kaplan DR, Miller FD: Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 2001;3:778-784.
75. Crigler L, Kazhanie A, Yoon TJ, Zakhari J, Taylor B, Virador VM: Isolation of a mesenchymal cell population from murine dermis that contains progenitors of multiple cell lineages. FASEB J 2007;21:2050-2063.
76. French MM, Rose S, Canseco J, Athanasiou KA: Chondrogenic differentiation of adult dermal fibroblasts. Ann Biomed Eng 2004;32:50-56.
77. Shiraishi I, Takamatsu T, Minamikawa T, Onouchi Z, Fujita S: Quantitative histological analysis of the human sinoatrial node during growth and aging. Circulation 1992;85:2176-2184.
78. Camelliti P, Green CR, LeGrice I, Kohl P: Fibroblast network in rabbit sinoatrial node: structural and functional identification of homogeneous and heterogeneous cell coupling. Circ Res 2004;94: 828-835
79. Mebius, RE: Organogenesis of lymphoid tissues. Nat Rev Immunol 2003;3:292-303.
80. Parsonage G, Filer AD, Haworth O, Nash GB, Rainger GE, Salmon M, Buckley CD: A stromal address code defined by fibroblasts. Trends Immunol 2005; 26:150-156.
81. Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O'Neil LA, Perretti M, Rossi AG, Wallace JL: Resolution of inflammation: state of the art, definitions and terms. FASEB J 2007;21:325-332.
82. Desmouliere A, Darby IA, Gabbiani G: Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab Invest 2003;83:1689-1707.
83. Kramann R, DiRocco DP, Humphreys BD: Understanding the origin, activation and regulation of matrixproducing myofibroblasts for treatment of fibrotic disease. J Pathol 2013;231:273-289.